Chapter 14-Antineoplastic

Question 1

Erlotinib

Answer 1

Inhibiting various kinases in specific cancer cells

Well absorbed orally from the GI tract, reaching peak levels in 4 hours

Associated with cardiovascular events and pulmonary toxicity.

Question 2

Elitek (Rasburicase)

Answer 2

Management of plasma uric acid levels in patients with leukemia, lymphoma, and solid tumor malignancies who are receiving antineoplastic therapy associated with tumor lysis and subsequent elevated serum acid levels

Question 3

COX-2 Inhibitor

Answer 3

Site of action: Induced by inflammatory stimuli at the site of inflammation

Effects: Increases pain, inflammation, vasodilates, blocks platelet clumping

Assess for GI effects, changes in bleeding time, and water retention

Can lead to CV problems due to potential of blocking the protective responses in the body such as vasodilation and inhibited platelet clumping, which is protective if vessel narrowing or blockage occurs

Question 4

When NSAIDS are combined with loop diuretics

Answer 4

Potential for decreased antihypertensive effect of beta blockers

Question 5

Chrysotherapy

Answer 5

Treat with gold salts

Gold is taken up my macrophage, which then inhibit phagocytosis

Auranofin (Ridaura)